The peptides frequently being referenced in reclassification conversations include: AOD-9604 BPC-157 Emideltide (DSIP Delta Sleep-Inducing Peptide) Epitalon (Epithalamin) GHK-Cu (Copper Peptide) Kisspeptin-10 KPV MOTS-C Semax Selank TB-500 (Thymosin Beta-4 Fragment) Thymosin Alpha-1 Despite public discussion, these peptides remain categorized as Category 2 under current FDA policy and are not eligible for patient-specific 503A compounding
MacLeods Bedford clinic
Supports immune response, detoxification, and skin health
Antu Kalathookunnel Antony, University of Illinois at Chicago, United States Updates Copyright 2022 Zhang, Sun, Jiang, Lu, Ding, Li, Tian and Wang
PT-141 works directly on the nervous system by increasing arousal, causing the brain to direct blood flow to the vagina and clitoris